SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results - 2I traveled to 13 countries in 2025. This small island nation surprised me the most.
- 3Building an Individual Brand: Illustrations from Powerhouses
- 4Before trips to Mars, we need better protection from cosmic rays
- 5HR exec caught on Coldplay 'kiss cam' with boss finally breaks her silence: 'I made a bad decision and had a couple of High Noons'
- Steinmeier honours Italian 'guest workers' who rebuilt German economy
- AfD faction in western Germany ousts councilman for firebrand speech
- Audits of 6 American Busssiness Class Flights
- More loons are filling Maine's lakes with their ghostlike calls
- California warns of death cap mushrooms outbreak resulting in 3 deaths
- A mom stopped giving her kids snacks — and sparked a debate about eating habits
- See a half-lit moon shine among the stars of Aquarius on Nov. 27
- Man triggers smoke bomb during failed crypto robbery
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
